Arthur O. Tzianabos
2018
In 2018, Arthur O. Tzianabos earned a total compensation of $4.3M as President and Chief Executive Officer at Homology Medicines, a 79% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $3,562,722 |
| Salary | $490,500 |
| Other | $9,893 |
| Total | $4,313,115 |
Tzianabos received $3.6M in option awards, accounting for 83% of the total pay in 2018.
Tzianabos also received $250K in non-equity incentive plan, $490.5K in salary and $9.9K in other compensation.
Rankings
In 2018, Arthur O. Tzianabos' compensation ranked 2,519th out of 14,244 executives tracked by ExecPay. In other words, Tzianabos earned more than 82.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,519 out of 14,244 | 82nd |
Division Manufacturing | 928 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 317 out of 2,128 | 85th |
Industry group Drugs | 257 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 200 out of 1,391 | 86th |
Source: SEC filing on April 25, 2019.
Tzianabos' colleagues
We found two more compensation records of executives who worked with Arthur O. Tzianabos at Homology Medicines in 2018.